Assessment of Salivary Adipokines Resistin, Visfatin, and Ghrelin as Type 2 Diabetes Mellitus Biomarkers
Type 2 diabetes mellitus (T2DM) is emerging as a metabolic epidemic worldwide. Pathologically, dysregulation of many biological pathways precedes hyperglycemia and the clinical diagnosis of T2DM. Changing trajectories along the process of T2DM development necessitates frequent measurement of biomark...
Saved in:
Main Authors: | Mythily Srinivasan, Melinda L. Meadows, Lisa Maxwell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Biochemistry Research International |
Online Access: | http://dx.doi.org/10.1155/2018/7463796 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013-01-01) -
Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women
by: Veronica Tisato, et al.
Published: (2017-01-01) -
Adipokines NUCB2/Nesfatin-1 and Visfatin as Novel Inflammatory Factors in Chronic Obstructive Pulmonary Disease
by: Sirpa Leivo-Korpela, et al.
Published: (2014-01-01) -
Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus
by: Nikolaos Vrachnis, et al.
Published: (2012-01-01) -
Impact of Bariatric Surgery on Ghrelin and Obestatin Levels in Obesity or Type 2 Diabetes Mellitus Rat Model
by: Donglei Zhou, et al.
Published: (2014-01-01)